2015
A Case Report of Enteric Duplication Cyst: A Unique Presentation With Multiple Rare Associations, Arsha Sreedhar MD, Ranjit R. Nair MD, and William Scialla DO (Poster)
The Genomic Landscape of Juvenile Myelomonocytic Leukemia., Elliot Stieglitz, Amaro N. Taylor-Weiner, Tiffany Y. Chang, Laura C. Gelston, Yong-Dong Wang, Tali Mazor, Emilio Esquivel, Ariel Yu, Sara Seepo, Scott R. Olsen, Mara Rosenberg, Sophie L. Archambeault, Ghada Abusin, Kyle Beckman, Patrick A. Brown, Michael Briones, Benjamin Carcamo, Todd Cooper, Gary V. Dahl, Peter D. Emanuel, Mark N. Fluchel, Rakesh K. Goyal, Robert J. Hayashi, Johann Hitzler, Christopher Hugge, Y Lucy Liu, Yoav H. Messinger, Donald H. Mahoney, Philip Monteleone MD, Eneida R. Nemecek, Philip A. Roehrs, Reuven J. Schore, Kimo C. Stine, Clifford M. Takemoto, Jeffrey A. Toretsky, Joseph F. Costello, Adam B. Olshen, Chip Stewart, Yongjin Li, Jing Ma, Robert B. Gerbing, Todd A. Alonzo, Gad Getz, Tanja A. Gruber, Todd R. Golub, Kimberly Stegmaier, and Mignon L. Loh (Article)
In The Groove: A Case Series of Groove Pancreatitis, Matthew Sullivan DO, Jeffrey Brodsky MD, Shashin Shah MD, and Hiral N. Shah MD (Poster)
Dynamical System Modeling of Immune Reconstitution after Allogeneic Stem Cell Transplantation Identifies Patients at Risk for Adverse Outcomes., Amir Toor MD, Roy T Sabo, Catherine H Roberts, Bonny L Moore, Salman R Salman, Allison F Scalora, May T Aziz, Ali S Shubar Ali, Charles E Hall, Jeremy Meier, Radhika M Thorn, Elaine Wang, Shiyu Song, Kristin Miller, Kathryn Rizzo, William B Clark, John M McCarty, Harold M Chung, Masoud H Manjili, and Michael C Neale (Article)
On The Organization Of Human T Cell Receptor Loc, Amir Toor MD, Abdullah A. Toor, and Masound H. Manjili (Article)
Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin., Siqin Ye; Bin Cheng; Gregory Y H Lip MD; Richard Buchsbaum; Ralph L. Sacco MD, MS; Bruce Levin PhD; Marco R. Di Tullio MD; Min Qian PhD; Douglas L. Mann MD; Patrick M. Pullicino MD; Ronald S. Freudenberger MD; John R. Teerlink MD; Jay P. Mohr MD; Susan Graham MD; Arthur J. Labovitz MD; Conrado J. Estol MD, PhD; Dirk J. Lok MD; Piotr Ponikowski MD, PhD; Stefan D. Anker MD, PhD; John L P Thompson PhD; and Shunichi Homma MD (Article)
2014
Assessing the Development of Multidisciplinary Care: Experience of the National Cancer Institute Community Cancer Centers Program., Eliot L. Friedman MD, Neetu Chawla, Paul T. Morris, Kathleen M. Castro, Angela C. Carrigan, Irene Prabhu Das, and Steven B. Clauser (Article)
A strategy to reduce donor-specific HLA Abs before allogeneic transplantation., Usama Gergis MD, MBA; S Mayer; B Gordon; T Mark; R Pearse; T Shore; and K Van Besien (Article)
Immunoblastic Follicular Lymphoma: A Very Unusual Transformation of Low-Grade Follicular Lymphoma., Shereen M. Gheith MD, Dennis B. Cornfield, Weiyi Chen, Pal Singh-Kahlon, and Basil Ahmed MD (Article)
Patient and Tumor Characteristics and BRAF and KRAS Mutations in ColonCancer, NCCTG/Alliance N0147., Wilson I. Gonsalves; Michelle R. Mahoney; Daniel J. Sargent; Garth D. Nelson; Steven R. Alberts MD, MPH; Frank A. Sinicrope; Richard M. Goldberg; Paul J. Limburg; Stephen N. Thibodeau; Axel Grothey; Joleen M. Hubbard; Emily Chan; Suresh G. Nair MD; Jeffrey L. Berenberg; and Robert R. McWilliams (Article)
Eosinophilic fasciitis as a paraneoplastic syndrome, a case report and review of the literature., Housam Haddad; Suchitra Sundaram; Cynthia Magro; and Usama Gergis MD, MBA (Article)
Comparison of FOLFIRI With or Without Cetuximab in Patients With Resected Stage III Colon Cancer; NCCTG (Alliance) Intergroup Trial N0147, Jocelin Huang; Suresh G. Nair MD; Michelle R. Mahoney; Garth D. Nelson; Anthony F. Shields; Emily Chan; Richard M. Goldberg; Sharlene Gill; Morton S. Kahlenberg; James T. Quesenberry; Stephen N. Thibodeau; Thomas C. Smyrk; Axel Grothey; Frank A. Sinicrope; Thomas A. Webb; Gist H. Farr; Barbara A. Pockaj; Jeffrey L. Berenberg; Margaret Mooney; Daniel J. Sargent; and Steven R. Alberts MD, MPH (Article)
In silico Derivation of HLA-Specific Alloreactivity Potential from Whole Exome Sequencing of Stem-Cell Transplant Donors and Recipients: Understanding the Quantitative Immunobiology of Allogeneic Transplantation., Max Jameson-Lee, Vishal Koparde, Phil Griffith, Allison F Scalora, Juliana K Sampson, Haniya Khalid, Nihar U Sheth, Michael Batalo, Myrna G Serrano, Catherine H Roberts, Michael L Hess, Gregory A Buck, Michael C Neale, Masoud H Manjili, and Amir Toor MD (Article)
Etiology of GVHD: alloreactivity or impaired cellular adaptation?, Masoud H Manjili and Amir Toor MD (Article)
Ectopic Cushing Syndrome and Pancreatic Cancer: A Case Report, Mira Mitry MD; Nicole M. Agostino DO; Stacey Smith MD, FACP; and Vasudev G. Magaji MD, MS (Poster)
A rare case of acute lymphoblastic leukemia in a patient with light chain (AL) amyloidosis treated with lenalidomide., Ranjit R. Nair MD; Shereen M F Gheith MD, PhD; Dan Popescu; and Nicole M. Agostino DO (Article)
Miss the Ear, and You May Miss the Diagnosis, Ranjit R. Nair MD and Yehia Y. Mishriki MD (Article)
Cutaneous lymphocyte antigen expression loss and PD1 positivity in early cutaneous lesions of rapidly progressive mycosis fungoides., Olakunle Ogunrinade; Christine S Ahn; Usama Gergis MD, MBA; Aminah H Yassin; and Cynthia Magro (Article)
Ablative therapies for colorectal polyps and malignancy., Jacqueline Oxenberg DO, Steven N Hochwald, and Steven Nurkin (Article)
The role of radiation therapy in melanoma., Jacqueline Oxenberg DO and John M Kane (Article)
Morbidity and mortality associated with gastrectomy for gastric cancer., Wesley A Papenfuss, Moshim Kukar, Jacqueline Oxenberg DO, Kristopher Attwood, Steven Nurkin, Usha Malhotra, and Neal W Wilkinson (Article)
Phase II Study of Nivolumab (anti-PD-1, BMS-936558, ONO-4538) in Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer: Metastatic Non-small Cell Lung Cancer, S S. Ramalingam, J Mazieres, D Planchard, T E. Stinchcombe, G K. Dy, S J. Antonia, L Horn, H Lena, E Minenza, B Mennecier, G A. Otterson, L T. Campos, D R. Gandara, B P. Levy, Suresh G. Nair MD, G Zalcman, J Wolf, C Baudelet, B J. Lestini, and N A. Rizvi (Article)
Whole exome sequencing to estimate alloreactivity potential between donors and recipients in stem cell transplantation., Juliana K Sampson, Nihar U Sheth, Vishal N Koparde, Allison F Scalora, Myrna G Serrano, Vladimir Lee, Catherine H Roberts, Max Jameson-Lee, Andrea Ferreira-Gonzalez, Masoud H Manjili, Gregory A Buck, Michael C Neale, and Amir Toor MD (Article)
Integrated Diabetes Oncology Care, Janelle M. Sharma DNP, CRNP; Gregory R. Harper MD, PhD; Cara Habeck RN, CDE; Cathy A. Coyne PhD, MPH; Roya Hamadani MPH; Hope Kincaid MPH, CPH; Ada M. Rivera BA; Gretchen A. Perilli MD; and Nicole R. Sully DO (Presentation)
Stem cell transplantation as a dynamical system: are clinical outcomes deterministic?, Amir Toor MD, Jared D Kobulnicky, Salman Salman, Catherine H Roberts, Max Jameson-Lee, Jeremy Meier, Allison Scalora, Nihar Sheth, Vishal Koparde, Myrna Serrano, Gregory A Buck, William B Clark, John M McCarty, Harold M Chung, Masoud H Manjili, Roy T Sabo, and Michael C Neale (Article)
Burkitt Lymphoma Presenting as Left Lateral Rectus Palsy, Daniel Tseytlin DO and Usman Shah MD (Poster)
Targeted immunotherapy for non-small cell lung cancer., Monali Vasekar, Xin Liu, Hong Zheng, and Chandra P Belani (Article)
Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission., Erica D Warlick; Kristjan Paulson; Ruta Brazauskas; Xiaobo Zhong; Alan M Miller; Bruce M Camitta; Biju George; Bipin N Savani; Celalettin Ustun; David I Marks; Edmund K Waller; Frédéric Baron; César O Freytes; Gérard Socie; Gorgun Akpek; Harry C Schouten; Hillard M Lazarus; Edwin M Horwitz; John Koreth; Jean-Yves Cahn; Martin Bornhauser; Matthew Seftel; Mitchell S Cairo; Mary J Laughlin; Mitchell Sabloff; Olle Ringdén; Robert Peter Gale; Rammurti T Kamble; Ravi Vij; Usama Gergis MD, MBA; Vikram Mathews; Wael Saber; Yi-Bin Chen; Jane L Liesveld; Corey S Cutler; Armin Ghobadi; Geoffrey L Uy; Mary Eapen; Daniel J Weisdorf; and Mark R Litzow (Article)
KRAS Codon 12 and 13 Mutations in Relation to Disease-freeSurvival in BRAF-wild-type Stage III Colon Cancers from an Adjuvant ChemotherapyTrial (N0147 Alliance)., Harry H. Yoon; David Tougeron; Qian Shi; Steven R. Alberts MD, MPH; Michelle R. Mahoney; Garth D. Nelson; Suresh G. Nair MD; Stephen N. Thibodeau; Richard M. Goldberg; Daniel J. Sargent; and Frank A. Sinicrope (Article)
Alterations of LKB1 and KRAS and Risk of Brain Metastasis: Comprehensive Characterization by Mutation Analysis, Copy Number, and Gene Expression in Non-Small-Cell Lung Carcinoma., Ni Zhao, Matthew D. Wilkerson, Usman Shah MD, Xiaoying Yin, Anyou Wang, Michele C. Hayward, Patrick Roberts, Carrie B. Lee, Alden M. Parsons, Leigh B. Thorne, Benjamin E. Haithcock, Juneko E. Grilley-Olson, Thomas E. Stinchcombe, William K. Funkhouser, Kwok-Kin Wong, Norman E. Sharpless, and D Neil Hayes (Article)
2013
Myelodysplastic syndromes: toward a risk-adapted treatment approach., Bishoy Faltas; Amer Zeidan; and Usama Gergis MD, MBA (Article)
Improving quality of care within the NCI Community Cancer Centers Program (NCCCP) network., Eliot L. Friedman MD (Article)
Thoracic Multidisciplinary Clinic (TMDC) and the Treatment of Stage III Non-Small Cell Lung Cancer, Eliot L. Friedman MD, Michael F. Szwerc MD, Robert Kruklitis MD, and Michael J. Weiss (Poster)
Predicting therapy response in live tumor cells isolated with the flexible micro spring array device., Jean-Nicolas Gallant, Elizabeth M Matthew, Hairong Cheng, Ramdane Harouaka, Nicholas Lamparella DO, Miriam Kunkel, Zhaohai Yang, Harold A Harvey, Leah V Cream, Suresh M Kumar, Gavin P Robertson, Siyang Zheng, Joseph J Drabick, Cristina I Truica, and Wafik S El-Deiry (Article)
A phase I study of CPX-351 in combination with busulfan and fludarabine conditioning and allogeneic stem cell transplantation in adult patients with refractory acute leukemia., Usama Gergis MD, MBA; Gail Roboz; Tsiporah Shore; Ellen Ritchie; Sebastian Mayer; Usama Wissa; Marshall McKenna; Paul Christos; Roger Pearse; Tomer Mark; Joseph Scandura; Koen van Besien; and Eric Feldman (Article)
Impact of genetic markers on treatment of non-small cell lung cancer., Nicholas Lamparella DO, Amit Barochia, and Salah Almokadem (Article)
Contradictory KRAS mutation test results in a patient with metastatic colon cancer: a clinical dilemma in the era of personalized medicine., Nicholas Lamparella DO, Bikramajit S Saroya, Zhaohai Yang, Nabeel E Sarwani, and Wafik S El-Deiry (Article)
A phase 1 study of bendamustine and melphalan conditioning for autologous stem cell transplantation in multiple myeloma., Tomer M Mark; Whitney Reid; Ruben Niesvizky; Usama Gergis MD, MBA; Roger Pearse; Sebastian Mayer; June Greenberg; Morton Coleman; Koen Van Besien; and Tsiporah Shore (Article)
Fractal organization of the human T cell repertoire in health and after stem cell transplantation., Jeremy Meier, Catherine Roberts, Kassi Avent, Allison Hazlett, Jennifer Berrie, Kyle Payne, David Hamm, Cindy Desmarais, Catherine Sanders, Kevin T Hogan, Kellie J Archer, Masoud H Manjili, and Amir Toor MD (Article)
Autologous stem cell transplant in human immunodeficiency virus-positive patients with lymphoid malignancies: focus on infectious complications., Ewelina Morawa; Peter Martin; Usama Gergis MD, MBA; Koen van Besien; and Tsiporah Shore (Article)
Melanoma Update, Suresh G. Nair MD (Presentation)
Hypoxia Induces Phenotypic Plasticity and Therapy Resistance in Melanoma via the Tyrosine Kinase Receptors ROR1 and ROR2, Michael p. O'Connell; Katie Marchbank; Marie R. Webster; Alexander A. Valiga; Amanpreet Kaur; Adina Vultur; Ling Li; Meenhard Herlyn; Jessie Villanueva; Qin Liu; Xiangfan Yin; Sandy Widura; Janelle Nelson; Nivia Ruiz; Tura C. Camilli; Fred E. Indig; Keith T. Flaherty; Jennifer A. Wargo; Dennie T. Frederick; Zachary A. Cooper; Suresh G. Nair MD; Ravi K. Amaravadi; Lynn M. Schuchter; Giorgos C. Karakousis; Wei Xu; Xiaowei Xu MD, PhD; and Ashani T. Weeraratna (Article)
Diabetic Ketoacidosis: A Review and Update, Gretchen Perilli MD, Christine Saraceni, Michael N. Daniels DO, and Aakif N. Ahmad DO (Article)
Dissecting Pin1 and phospho-pRb regulation., Flavio Rizzolio, Isabella Caligiuri, Chiara Lucchetti, Roberto S Fratamico MD, Valentina Tomei, Gaia Gallo, Alexis Agelan, Giovanni Ferrari, Giuseppe Toffoli, Andres J Klein-Szanto, and Antonio Giordano (Article)
An Outcome-Adaptive Allocation Method for Clinical Trials With Dual Binary Objectives, Roy T. Sabo, Cathy Roberts, Amir Toor MD, and John M. McCarty (Article)
Plasmablastic Lymphoma of the Maxillary Sinus in an HIV-negative Patient: a Case Report and Literature Review, Christine Saraceni, Nicole M. Agostino DO, Dennis B. Cornfield MD, and Ranju Gupta MD (Article)
Emerging molecular therapies for the treatment of acute lymphoblastic leukemia., Monali Vasekar, Joshua E Allen, Jamal Joudeh, and David Claxton (Article)
Fatal malignant metastastic epithelioid angiomyolipoma presenting in a young woman: case report and review of the literature., Edward Wyluda, Giselle Baquero, Nicholas Lamparella DO, Catherine Abendroth, and Joseph Drabick (Article)
Early-Phase Clinical Trials in the Community: Results from the National Cancer Institute Community Cancer Centers Program Early-Phase Working Group Baseline Assessment., Howard A. Zaren, Suresh G. Nair MD, Ronald S. Go, Rebecca A. Enos, Keith S. Lanier, Michael A. Thompson, Jinxiu Zhao, Deborah L. Fleming, John C. Leighton, Thomas E. Gribbin, Donna M. Bryant, Angela Carrigan, Jennifer C. Corpening, Kimberly A. Csapo, Eileen P. Dimond, Christie Ellison, Maria M. Gonzalez, Jodi L. Harr, Kathy Wilkinson, and Andrea M. Denicoff (Article)
2012
Cediranib (AZD2171) in Patients With Advanced Hepatocellular Carcinoma: A Phase II North Central Cancer Treatment Group Clinical Trial, Steven R. Alberts MD, MPH; Tom R. Fitch MD; George P. Kim MD; Bruce W. Morlan MS; Shaker R. Dakhil MD; Howard M. Gross MD; and Suresh G. Nair MD (Article)
Effect of Oxaliplatin, Fluorouracil, and Leucovorin with or Without Cetuximab on Survival Among Patients with Resected Stage III Colon Cancer: A Randomized Trial., Steven R. Alberts MD, MPH; Daniel J. Sargent; Suresh G. Nair MD; Michelle R. Mahoney; Margaret Mooney; Stephen N. Thibodeau; Thomas C. Smyrk; Frank A. Sinicrope; Emily Chan; Sharlene Gill; Morton S. Kahlenberg; Anthony F. Shields; James T. Quesenberry; Thomas A. Webb; Gist H. Farr; Barbara A. Pockaj; Axel Grothey; and Richard M. Goldberg (Article)
The hedgehog pathway in breast cancer., Sheikh Asim Ali MD (Article)
Survival outcomes in pregnancy associated breast cancer: a retrospective case control study., Sheikh Asim Ali MD, Sameer Gupta, Rajesh Sehgal, and Victor Vogel (Article)
Distinct oligoclonal T cells are associated with graft versus host disease after stem-cell transplantation., Jennifer L Berrie, Maciej Kmieciak, Roy T Sabo, Catherine H Roberts, Michael O Idowu, Katherine Mallory, Harold M Chung, John M McCarty, Christian A Borrelli, Michelle M Detwiler, A Latif Kazim, Amir Toor MD, and Masoud H Manjili (Article)
Current status of allogeneic HST for chronic myelomonocytic leukemia., H Cheng; V G Kirtani; and Usama Gergis MD, MBA (Article)
Philadelphia Chromosome-Negative Myeloproliferative Neoplasm with a Novel Platelet-Derived Growth Factor Receptor-β Rearrangement Responsive to Imatinib, Dennis B. Cornfield MD, Usman Shah MD, Nicholas Cross, Courtney E. Bennett DO, and Guoxian Sun (Article)
Autologous stem cell transplant is feasible in very elderly patients with lymphoma and limited comorbidity., Rebecca L Elstrom; Peter Martin; Sandra Hurtado Rua; Tsiporah B Shore; Richard R Furman; Jia Ruan; Roger N Pearse; Morton Coleman; Tomer Mark; John P Leonard; and Usama Gergis MD, MBA (Article)
Risk assessment in human immunodeficiency virus-associated acute myeloid leukemia., Michael W. Evans MD, MPH; Anthony D Sung; Ivana Gojo; Michael Tidwell; Jacqueline Greer; Mark Levis; Judith Karp; and Maria R Baer (Article)
Management of refractory acute myeloid leukemia: re-induction therapy or straight to transplantation?, E J Feldman and Usama Gergis MD, MBA (Article)
Evolution of multidisciplinary care: Experience of the National Cancer Institute (NCI) Community Cancer Centers Program (NCCCP)., Eliot L. Friedman MD (Article)
Utility of FDG PET-CT Scan in Determining Pathological Response to Neo-adjuvant Chemo-radiation Therapy in Non-small Cell Lung Cancer (NSCLC), Eliot L. Friedman MD, Michael F. Szwerc MD, Robert Kruklitis MD, Michael J. Weiss MPH, Robert Rienzo MD, and Wen Young MD (Poster)
Successful treatment with tacrolimus of a patient with severe idiopathic thrombocytopenic purpura after allogeneic bone marrow transplantation., Usama Gergis MD, MBA; Mohammed Ibrahim; Mohamed Al-Kazaz; Sonam Parkash; Enas Gergis; and Maria Desancho (Article)
Early-phase (EP) clinical trials (CTs) in the community: Results from the National Cancer Institute (NCI) Community Cancer Centers Program (NCCCP) Early-Phase Working Group (EPWG) Baseline Assessment Study (BAS)., Ronald S. Go, Howard Zaren, and Suresh G. Nair MD (Presentation)
Is port site resection necessary in the surgical management of gallbladder cancer?, Ajay V Maker, Jean M Butte, Jacqueline Oxenberg DO, Deborah Kuk, Mithat Gonen, Yuman Fong, Ronald P Dematteo, Michael I D'Angelica, Peter J Allen, and William R Jarnagin (Article)
Immunotherapy of cancer: reprogramming tumor-immune crosstalk., Kyle K Payne, Amir Toor MD, Xiang-Yang Wang, and Masoud H Manjili (Article)
Anti-thymocyte globulin for conditioning in matched unrelated donor hematopoietic cell transplantation provides comparable outcomes to matched related donor recipients., D A Portier, R T Sabo, C H Roberts, D S Fletcher, J Meier, W B Clark, M C Neale, M H Manjili, J M McCarty, H M Chung, and Amir Toor MD (Article)
Community Cancer Services, Clinical Trials, and Quality Initiatives--Year 2 NCCCP at Lehigh Valley Health Network, Ada M. Rivera BA; Lenore A. McGonigle Ms; MaryEllen Shiels BS; Smiyyah Q. Whitney RN; Suresh G. Nair MD; Janelle M. Sharma; Kathy Sevedge RN, MA, AOCN; Eliot L. Friedman MD; Nadesda Mack RN, BSN, MBA, OCN; and Gregory R. Harper MD, PhD (Poster)
Are low-intensity induction strategies better for older patients with acute myeloid leukemia?, Gail J Roboz; Usama Wissa; Ellen K Ritchie; Usama Gergis MD, MBA; Sebastian Mayer; Joseph M Scandura; Paul J Christos; and Eric J Feldman (Article)
Perceived levels of pain associated with bone marrow aspirates and biopsies., Giampaolo Talamo, Jason Liao, Jamal Joudeh, Nicholas Lamparella DO, Hoang Dinh, Jozef Malysz, and W Christopher Ehmann (Article)
Epigenetic induction of adaptive immune response in multiple myeloma: sequential azacitidine and lenalidomide generate cancer testis antigen-specific cellular immunity., Amir Toor MD, Kyle K Payne, Harold M Chung, Roy T Sabo, Allison F Hazlett, Maciej Kmieciak, Kimberly Sanford, David C Williams, William B Clark, Catherine H Roberts, John M McCarty, and Masoud H Manjili (Article)
Favorable outcomes in patients with high donor-derived T cell count after in vivo T cell-depleted reduced-intensity allogeneic stem cell transplantation., Amir Toor MD, Roy T Sabo, Harold M Chung, Catherine Roberts, Rose H Manjili, Shiyu Song, David C Williams, Wendy Edmiston, Mandy L Gatesman, Richard W Edwards, Andrea Ferreira-Gonzalez, William B Clark, Michael C Neale, John M McCarty, and Masoud H Manjili (Article)
ACE inhibitor-induced angioedema., Monali Vasekar and Timothy J Craig (Article)
2011
Transformation of the 5q- Syndrome to Acute Lymphoblastic Leukemia: A Report of Two Cases and Review of the Literature, Nicole M. Agostino DO, Basil Ahmed MD, Dan Popescu MD, and Shereen M. Gheith MD (Article)
Effect of the Tyrosine Kinase Inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on Blood Glucose Levels in Diabetic and Nondiabetic Patients in General Clinical Practice, Nicole M. Agostino DO; Vernon M. Chinchilli PhD; Christopher J. Lynch PhD; Anita M. Koszyk-Szewczyk MD; Rebecca Gingrich RN, MS, OCN; Jeffrey Sivik D Pharma; and Joseph J. Drabick MD, FACP (Article)
Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043)., Kenneth I Ataga, Marvin Reid, Samir K Ballas, Zahida Yasin, Carolyn Bigelow, Luther St James, Wally R Smith, Frederic Galacteros, Abdullah Kutlar, James H Hull, Jonathan W Stocker, and Maged Khalil MD (Article)
Large vocal fold polyp., Venu Divi, Robert T Sataloff, and Jacqueline Oxenberg DO (Article)
Mid-term Analysis of IIIA NSCLC Patients Treated With Neoadjuvant Chemoradiation Followed by Surgical Resection, Eliot L. Friedman MD (Presentation)
Neo-adjuvant Chemotherapy and Radiation Therapy in Patients with Stage IIIA (N2) Non-Small Cell Lung Cancer (NSCLC): A Retrospective Analysis with Lessons Learned, Eliot L. Friedman MD, Michael F. Szwerc MD, Charles Andrews MD, Robert Kruklitis MD, Kathleen A. Leies, and Ferdy Santiago (Poster)
Autologous hematopoietic stem-cell transplantation in combination with thalidomide as treatment for histiocytic sarcoma: a case report and review of the literature., Usama Gergis MD, MBA; Hendrik Dax; Ellen Ritchie; Rachel Marcus; Usama Wissa; and Attilio Orazi (Article)
PRKN, DJ-1, and PINK1 screening identifies novel splice site mutation in PRKN and two novel DJ-1 mutations., Farzaneh Ghazavi, Zeinab Fazlali, Setareh Sadat Banihosseini, Sayed-Rzgar Hosseini, Mohammad Hossein Kazemi MD, Seyedmehdi Shojaee, Khosro Parsa, Homa Sadeghi, Farzad Sina, Mohammad Rohani, Gholam-Ali Shahidi, Nasser Ghaemi, Mostafa Ronaghi, and Elahe Elahi (Article)
Community Cancer Services, Clinical Trials, and Quality Initiatives—Year 1 NCCCP at Lehigh Valley Health Network, Gregory R. Harper MD, PhD; Ada M. Rivera BA; Eliot L. Friedman MD; Kathleen A. Leies RN, OCN; Nadesda Mack RN, BSN, MBA, OCN; Lenore McGonigle Med; Suresh G. Nair MD; Tara Namey MS, CGC; Debbie Salas-Lopez MD, MPH, FACP; and Ronald W. Swinfard MD, FACP (Poster)
Activated NKT cells and NK cells render T cells resistant to myeloid-derived suppressor cells and result in an effective adoptive cellular therapy against breast cancer in the FVBN202 transgenic mouse., Maciej Kmieciak, Debasmita Basu, Kyle K Payne, Amir Toor MD, Adly Yacoub, Xiang-Yang Wang, Lisa Smith, Harry D Bear, and Masoud H Manjili (Article)
Ex vivo expansion of tumor-reactive T cells by means of bryostatin 1/ionomycin and the common gamma chain cytokines formulation., Maciej Kmieciak, Amir Toor MD, Laura Graham, Harry D Bear, and Masoud H Manjili (Article)
Comment on "Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses"., Masoud H Manjili and Amir Toor MD (Article)
Exploring therapeutic decisions in elderly patients with non-small cell lung cancer: results and conclusions from North Central Cancer Treatment Group Study N0222., Heidi Mc Kean, Philip J Stella, Shauna L Hillman, Kendrith M Rowland, Michael W Cannon, Robert J Behrens, Gerald G Gross, Mark D Sborov, Eliot L. Friedman MD, and Aminah Jatoi (Article)
Early success in narrowing age, gender, and racial disparities in clinical trial accrual: Targeted screening efforts through the National Cancer Institute Community Cancer Centers Program (NCCCP)., Suresh G. Nair MD (Article)
Influence of KRAS and BRAF mutational status and rash on disease-free survival (DFS) in patients with resected stage III colon cancer receiving cetuximab (Cmab): Results from NCCTG N0147., Suresh G. Nair MD (Article)
Pilot experience with adjuvant FOLFIRI with or without cetuximab in patients with resected stage III colon cancer: NCCTG Intergroup N0147., Suresh G. Nair MD (Article)
Quality of life (QOL) for patients treated with FOLFOX with or without cetuximab (Cmab) following complete resection of colorectal cancer (CRC): Results from North Central Cancer Treatment Group (NCCTG) phase III trial N0147, Suresh G. Nair MD (Article)
Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML., Joseph M Scandura; Gail J Roboz; Michelle Moh; Ewelina Morawa; Fabienne Brenet; J Robi Bose; Luis Villegas; Usama Gergis MD, MBA; Sebastian A Mayer; Cindy M Ippoliti; Tania J Curcio; Ellen K Ritchie; and Eric J Feldman (Article)
2010
Effect of the Tyrosine Kinase Inhibitors (Sunitinib, Sorafenib, Dasatinib, and Imatinib) on Blood Glucose Levels in Diabetic and Non-diabetic Patients in General Clinical Practice (Poster), Nicole M. Agostino DO; Vernon M. Chinchilli PhD; Christopher J. Lynch PhD; Anita M. Koszyk-Szewczyk MD; Rebecca Gingrich RN, MS, OCN; Jeffery Sivik D Pharma; and Joseph J. Darbick MD, FACP (Poster)
Bevacizumab Demonstrates Prolonged Disease Stabilization in Patients with Heavily Pretreated Metastatic Renal Cell Carcinoma: A Case Series and Review of the Literature, Nicole M. Agostino DO and Rebecca Gingrich (Article)
The role of CD40L and VEGF in the modulation of angiogenesis and inflammation., Subrata Chakrabarti, Muhammad A. Rizvi MD, Kristine Morin, Ravi Garg, and Jane E Freedman (Article)
A Front-Line Window of Opportunity Phase 2 Study of Sorafenib in Patients with Advanced Nonsmall Cell Lung Cancer: North Central Cancer Treatment Group Study N0326., Grace K. Dy, Shauna L. Hillman, Kendrith M. Rowland, Julian R. Molina, Preston D. Steen MD, Donald B. Wender, Suresh G. Nair MD, Sumithra Mandrekar, Steven E. Schild, and Alex A. Adjei (Article)
Rituximab treatment for thrombotic thrombocytopenic purpura associated with human immunodeficiency virus failing extensive treatment with plasma exchange: a report of two cases., Michael W. Evans MD, MPH; Leroy B Vaughan; Victoria S Giffi; Ann B Zimrin; and John R Hess (Article)
Multidisciplinary Survivorship Care, Sue N. Gardner RN, MSN, CRNP, AOCNP; Gregory Harper MD, PhD; Dorothy Morrone RNC, MS, OCN; Jennifer Brennan RD, CSO; Andrea Geshan RN, MSW; Diane Brong LCSW; and Jennifer Roeder MSPT, MBA (Poster)
Randomized phase III trial of pegfilgrastim versus filgrastim after autologus peripheral blood stem cell transplantation., Aaron Gerds, Mary Fox-Geiman, Kevin Dawravoo, Tulio Rodriguez, Amir Toor MD, Scott Smith, Karen Kiley, Donna Fletcher-Gonzalez, Chindo Hicks, and Patrick Stiff (Article)
Effectiveness and safety of tocilizumab, an anti-interleukin-6 receptor monoclonal antibody, in a patient with refractory GI graft-versus-host disease., Usama Gergis MD, MBA; Jon Arnason; Rhonda Yantiss; Tsiporah Shore; Usama Wissa; Eric Feldman; and Thasia Woodworth (Article)
Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD., Usama Gergis MD, MBA; K Markey; J Greene; M Kharfan-Dabaja; T Field; G Wetzstein; M J Schell; Y Huang; C Anasetti; and J Perkins (Article)
High-risk myelodysplastic syndromes: chemotherapy, transplantation, and beyond., Usama Gergis MD, MBA and Usama Wissa (Article)